Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Esther L. Davis, Peter J. Kelly, Frank P. Deane, Amanda L. Baker, Mark Buckingham, Tayla Degan & Sarah Adams. (2020) The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: A systematic literature review . Substance Abuse 41:2, pages 216-231.
Read now
Read now
Alissa Merielle Greer, Bernadette Pauly, Alex Scott, Ruth Martin, Charlene Burmeister & Jane Buxton. (2019) Paying people who use illicit substances or ‘peers’ participating in community-based work: a narrative review of the literature. Drugs: Education, Prevention and Policy 26:6, pages 447-459.
Read now
Read now
Joan Trujols, Ioseba Iraurgi, Eugenia Oviedo-Joekes & Joan Guàrdia-Olmos. (2014) A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study. Patient Preference and Adherence 8, pages 107-117.
Read now
Read now
Nick Doukas. (2011) Perceived barriers to identity transformation for people who are prescribed methadone. Addiction Research & Theory 19:5, pages 408-415.
Read now
Read now
Nick Doukas. (2011) Older Adults in Methadone Maintenance Treatment: A Literature Review. Journal of Social Work Practice in the Addictions 11:3, pages 230-244.
Read now
Read now
Adam R. Winstock & Toby Lea. (2010) Diversion and Injection of Methadone and Buprenorphine Among Clients in Public Opioid Treatment Clinics in New South Wales, Australia. Substance Use & Misuse 45:1-2, pages 240-252.
Read now
Read now
Carla Treloar & Martin Holt. (2008) Complex vulnerabilities as barriers to treatment for illicit drug users with high prevalence mental health co-morbidities. Mental Health and Substance Use 1:1, pages 84-95.
Read now
Read now
Annie Madden, Annie Madden, Toby Lea, Annie Madden, Toby Lea, Nicky Bath, Annie Madden, Toby Lea, Nicky Bath, Adam R. Winstock, Annie Madden, Toby Lea, Nicky Bath & Adam R. Winstock. (2008) Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug and Alcohol Review 27:6, pages 671-678.
Read now
Read now
Articles from other publishers (28)
Louise Atkinson. (2023) “In my own comfort zone”: Clients' experiences of relational aspects of online therapy for alcohol problems. Counselling and Psychotherapy Research 23:4, pages 1005-1014.
Crossref
Crossref
Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter & Eugenia Oviedo-Joekes. (2023) The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review. Substance Abuse Treatment, Prevention, and Policy 18:1.
Crossref
Crossref
Anna Conway, Alison D. Marshall, Sione Crawford, Jeremy Hayllar, Jason Grebely & Carla Treloar. (2023) Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study. Implementation Science 18:1.
Crossref
Crossref
Eve Allen, Sona Samadian, Gary Altobelli, Jacinta Johnson & Chris Holmwood. (2023) Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed‐methods study. Drug and Alcohol Review 42:4, pages 791-802.
Crossref
Crossref
Natasha Yvonne Hall, Long Le, Julie Abimanyi-Ochom, Maree Teesson & Cathy Mihalopoulos. (2023) Identifying the most common barriers to opioid agonist treatment in an Australian setting. Australian Journal of Primary Health 29:5, pages 445-454.
Crossref
Crossref
Richard Mellor, Matthew Kearnes, Kari Lancaster, Laura McLauchlan & Alison Ritter. (2022)
Established
Tables
and Emergent
Huddles:
Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19
. Contemporary Drug Problems 49:4, pages 385-404.
Crossref
Crossref
Robert A Kleinman, Suzanne Nielsen & Roger D Weiss. (2022) Is daily supervised buprenorphine-naloxone dosing necessary?. BMJ, pages e071467.
Crossref
Crossref
Natasha Yvonne Hall, Long Le, Ishani Majmudar & Cathrine Mihalopoulos. (2021) Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence 221, pages 108651.
Crossref
Crossref
Amy B. Jessop, Sarah Bauerle Bass, Jesse Brajuha, Mohammed Alhajji, Monika Burke, Muhamed Tahar Gashat, Carine Wellington, Nicole Ventriglia, Jennie Coleman & Paul D'Avanzo. (2020) “Take Charge, Get Cured”: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy. Journal of Substance Abuse Treatment 109, pages 23-33.
Crossref
Crossref
Tejaswini Patil Vishwanath, Penelope Cash, Wendy Penney & Robyn Cant. (2018) A Narrative Review of Pharmacotherapy Treatment for Opioid Addiction and Application in a Community-Based Model in Victoria, Australia. International Journal of Mental Health and Addiction 18:1, pages 66-76.
Crossref
Crossref
Andrea Lynn Murphy & David Martin Gardner. (2019) Pharmacists’ acceptability of a men’s mental health promotion program using the Theoretical Framework of Acceptability. AIMS Public Health 6:2, pages 195-208.
Crossref
Crossref
Phuong-Phi Le. (2019) Patient access to opioid substitution treatment pharmacy and medical service providers in South Australia: geospatial mapping. Australian Journal of Primary Health 25:2, pages 125.
Crossref
Crossref
Alissa M. Greer, Ashraf Amlani, Bernadette Pauly, Charlene Burmeister & Jane A. Buxton. (2018) Participant, peer and PEEP: considerations and strategies for involving people who have used illicit substances as assistants and advisors in research. BMC Public Health 18:1.
Crossref
Crossref
Kari Lancaster, Alison Ritter & Rosalyn Diprose. (2018) Recasting Participation in Drug Policy. Contemporary Drug Problems 45:4, pages 351-365.
Crossref
Crossref
Rossio Motta-Ochoa, Karine Bertrand, Jorge Flores-Aranda, Catherine Patenaude, Natacha Brunelle, Michel Landry & Serge Brochu. (2017) A Qualitative Study of Addiction Help-Seeking in People with Different Co-occurring Mental Disorders and Substance Use Problems. International Journal of Mental Health and Addiction 15:4, pages 883-899.
Crossref
Crossref
K. Lancaster, K. Seear, C. Treloar & A. Ritter. (2017) The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes. Social Science & Medicine 176, pages 60-68.
Crossref
Crossref
Lynda Berends, Jenny Chalmers & Kari Lancaster. (2015) Trust, agency and control: Perspectives on methadone takeaway dosing in the context of the Victorian policy review. Drug and Alcohol Review 34:5, pages 483-486.
Crossref
Crossref
Caitlin Notley, Richard Holland, Vivienne Maskrey, Jessica Nagar & Christos Kouimtsidis. (2014) Regaining control: The patient experience of supervised compared with unsupervised consumption in opiate substitution treatment. Drug and Alcohol Review 33:1, pages 64-70.
Crossref
Crossref
Hanna Uosukainen, Hannu Pentikäinen & Ulrich Tacke. (2013) The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone—experience from a medium-sized Finnish city. Journal of Substance Abuse Treatment 45:1, pages 143-147.
Crossref
Crossref
Jake Rance, Jamee Newland, Max Hopwood & Carla Treloar. (2012) The politics of place(ment): Problematising the provision of hepatitis C treatment within opiate substitution clinics. Social Science & Medicine 74:2, pages 245-253.
Crossref
Crossref
BRIONY LARANCE, LOUISA DEGENHARDT, SUSANNAH O'BRIEN, NICK LINTZERIS, ADAM WINSTOCK, RICHARD P. MATTICK, JAMES BELL & ROBERT ALI. (2011) Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug and Alcohol Review 30:6, pages 613-620.
Crossref
Crossref
Tatja Kostnapfel, Igor ?vab & Danica P Rotar. (2011) A qualitative exploration of travel-related risk behaviours of injection drug users from two Slovene regions. Harm Reduction Journal 8:1, pages 8.
Crossref
Crossref
Adam R. Winstock, Toby Lea & Janie Sheridan. (2010) Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia. Addiction 105:2, pages 335-342.
Crossref
Crossref
I. Bilbao Acedos, Ó. Lozano Rojas, R. Ballesta Gómez & F. González-Saiz. (2009) Análisis cualitativo de la percepción del tratamiento con buprenorfina sublingual para la retirada del tratamiento con metadona. Trastornos Adictivos 11:4, pages 257-265.
Crossref
Crossref
Kylie Valentine. (2009) Evidence, values and drug treatment policy. Critical Social Policy 29:3, pages 443-464.
Crossref
Crossref
Adam R. Winstock, Toby Lea & Janie Sheridan. (2008) Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy 19:6, pages 450-458.
Crossref
Crossref
Toby Lea, Janie Sheridan & Adam Winstock. (2008) Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Pharmacy World & Science 30:6, pages 940-946.
Crossref
Crossref
Kylie valentine & Suzanne Fraser. (2008) Trauma, damage and pleasure: Rethinking problematic drug use. International Journal of Drug Policy 19:5, pages 410-416.
Crossref
Crossref